Australia invests $13.3m in commercialising digital health research | Healthcare Asia Magazine
, Australia
210 views
Photo from Envato

Australia invests $13.3m in commercialising digital health research

Six companies will receive a share of $2.5m (A$3.75m) to develop medical technologies. 

The Australian government has announced an investment of $13.3m (A$20m) to commercialise digital health research on neurological disorders such as multiple sclerosis and dementia.

The investment will support six companies that are set to receive a share of $2.5m (A$3.75m) funding from the government as part of a programme run by ANDHealth+ to support early-stage development of technologies with commercial potential.

In line with this, ANDHealth+ received approximately $13.1m (A$19.75m) through the Medical Research Future Fund’s (MRFF) Medical Research Commercialisation initiative.

“These investments will support Australia’s highest-potential digital health innovators to navigate the complex and evolving landscape of digital health commercialisation, providing hands-on support and access to leading experts from around the globe.” ANDHealth+ CEO, Bronwyn Le Grice, said.

Currently, the MRFF investment has supported 21 companies in their research for digital health solutions.

(A$1 = US$0.66)

 

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!